DC
Debjit Chattopadhyay Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
37
Avg Return
Past Year
Past Year
28%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $284 |
8%
upside
| 1 | +45% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Buy
Maintained
| $86 |
47%
upside
| 1 | -2.7% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Buy
Maintained
| $45 |
48%
upside
| 1 | -15% |
0
%
| 19 Feb ‘26 13 days ago |
|
|
|
Buy
Maintained
| $7 |
9%
upside
| 1 | +91% |
0
%
| 18 Feb ‘26 13 days ago |
|
|
|
Buy
Initiated
| $20 |
69%
upside
| 1 | +9.5% |
0
%
| 11 Feb ‘26 21 days ago |
|
|
|
Buy
Maintained
| $52 |
136%
upside
| 1 | -22% |
0
%
| 5 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $6 |
94%
upside
| 1 | +19% |
0
%
| 12 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $39 |
46%
upside
| 1 | -8.9% |
0
%
| 4 Dec ‘25 3 months ago |
|